COVID-19 third shot administration starts in Australia

2 min read | November 09, 2021 03:23 AM GMT | By Sonal Goyal

Highlights

  • The booster vaccination program has begun in Australia.
  • The program began formally on Monday, but on Saturday itself 173,000 doses have already been administered.
  • The update on the vaccination among children was also provided by the health minister of Australia.

The booster vaccination program began in Australia on 8 November 2021. In the program, people above 18 and have received their 2nd dose of vaccination, six months ago can register themselves for the third dose of COVID-19 vaccination.

The program began formally on Monday, but on Saturday itself 173,000 doses have already been administered.

The Pfizer vaccination is administered to people irrespective of the previous vaccination jabs. The experts recommended that Pfizer is the preferred vaccine and AstraZeneca should be given to those who observed adverse reaction mRNA vaccination. Also, AstraZeneca is to be given to those who received it as their primary course.

Moderna vaccines will also be included in the booster program when it will receive their final approval from eth regulatory authorities.

As per the government guidelines, getting the booster shot is not compulsory for getting exemptions for the COVID-19 related restrictions.

Greg Hunt, Health Minister stated that two doses of the COVID-19 vaccine extend good protection against severe diseases but the vaccines are not efficient in preventing transmission over time.

He also added that, at present, there is no global view whether vaccination should be made an annual program or fourth vaccination is required.

An update on the vaccination of children has also been provided by Hunt. He said that there are very less chances that it will take place this year. The delay is happening because none of the vaccines has gotten any approval for young children.

Pfizer has gained approval in the US and Pfizer is looking for approval in Australia as well. Hunt commented on the same that regulators are waiting for paperwork to be submitted.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalised advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.


Sponsored Articles


Investing Ideas

Previous Next